VIKASH CHIRAAG MODI
Allopathic & Osteopathic Physicians|Family Medicine ATLANTA, GA NPI 1780905018
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine GA ABBVIE INC. All categories
General Payments — all program years on this page
$7,803.72
- Category: General Payments
- Program years: PY2018–2024
- Record count: 395
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $745.81 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $745.81 | 42 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $207.07 | 15 |
| PFIZER INC. | $99.80 | 5 |
| Gilead Sciences, Inc. | $61.91 | 2 |
| Exact Sciences Corporation | $54.11 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.47 | 2 |
| Novo Nordisk AS | $42.13 | 2 |
| Lilly USA, LLC | $34.41 | 2 |
| Noven Therapeutics, LLC | $24.11 | 1 |
| Tris Pharma Inc | $23.81 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.57 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.99 | 1 |
| Abbott Laboratories | $19.00 | 1 |
| GlaxoSmithKline, LLC. | $17.30 | 1 |
| Dynavax Technologies Corporation | $16.79 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.45 | 1 |
| Astellas Pharma US Inc | $15.22 | 1 |
| Merck Sharp & Dohme Corporation | $14.71 | 1 |
| Currax Pharmaceuticals LLC | $13.96 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.